Fidelity Investments’s Co-Diagnostics CODX Stock Holding History

Fidelity Investments’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21	Buy	+7	New	+$22	﹤0.01%	5505
2025 Q1	–	Sell	-7	Closed	-$164	–	5355
2024 Q4	$164	Buy	+7	New	+$221	﹤0.01%	5067
2024 Q1	–	Sell	-25	Closed	-$1.01K	–	5409
2023 Q4	$1.01K	Sell	25 -1	-4%	-$35	﹤0.01%	4746
2023 Q3	$811	Buy	26 +1	+4%	+$38	﹤0.01%	4672
2023 Q2	$846	Sell	25 -181	-88%	-$6.93K	﹤0.01%	4739
2023 Q1	$9.15K	Buy	206 +152	+281%	+$12.2K	﹤0.01%	4160
2022 Q4	$4.07K	Buy	54 +29	+116%	+$2.71K	﹤0.01%	4322
2022 Q3	$2K	Hold	25	–	–	﹤0.01%	4530
2022 Q2	$4K	Hold	25	–	–	﹤0.01%	4362
2022 Q1	$5K	Buy	25 +8	+47%	+$1.66K	﹤0.01%	4419
2021 Q4	$4K	Sell	17 -5	-23%	-$1.31K	﹤0.01%	3848
2021 Q3	$6K	Buy	22 +11	+100%	+$3.21K	﹤0.01%	3727
2021 Q2	$3K	Buy	11 +8	+267%	+$2.06K	﹤0.01%	3825
2021 Q1	$1K	Buy	+3	New	+$1.2K	﹤0.01%	3814
2020 Q4	–	Hold	0	–	–	–	3869
2020 Q3	–	Hold	0	–	–	–	3713
2020 Q2	–	Hold	0	–	–	–	3651

Other funds holding CODX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAG

Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments's CODX Position: Q2 2026 in Review

Fidelity Investments opened a new position in Co-Diagnostics (CODX) in Q2 2026: 7 shares worth $21. The stake represents ﹤0.01% of the portfolio and ranks #5505 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in CODX as recently as Q4 2024.

Fidelity Investments first reported a position in CODX in Q1 2021 and has held it in 14 quarters since. The position peaked at $9.15K in Q1 2023. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

Fidelity Investments held 7 shares of Co-Diagnostics worth $21 as of Q2 2026.
Co-Diagnostics was a new Fidelity Investments position in Q2 2026.
Co-Diagnostics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5505 holding.
Fidelity Investments first reported a position in Co-Diagnostics in Q1 2021 and has held it in 14 quarters since.
Fidelity Investments's Co-Diagnostics position peaked at $9.15K in Q1 2023.
24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.